Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8741295 PD-1 antibodies and PD-L1 antibodies and uses thereof

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Daniel Olive0

Date of Patent

June 3, 2014

0

Patent Application Number

131484200

Date Filed

February 9, 2010

0

Patent Citations Received

US Patent 12089575 Genetically modified mouse that expresses humanized PD1 and PD-L1 proteins

0

US Patent 11986466 Methods of treating solid tumors with CCR2 antagonists

0

US Patent 11993653 Antibodies and methods of use thereof

0

0

0

US Patent 11685775 Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibody

0

US Patent 11744822 Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitors

US Patent 11753473 Anti-PD-L1 antibodies

...

Patent Primary Examiner

Elizabeth C. Kemmerer

0

Patent abstract

The invention relates to PD-1 antibodies and PD-L1 antibodies and uses thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8741295 PD-1 antibodies and PD-L1 antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool